Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adiponectin: systemic contributor to insulin sensitivity.

Utpal B Pajvani1, Philipp E Scherer

  • 1Department of Cell Biology and Diabetes Research and Training Center, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.

Current Diabetes Reports
|May 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A distinct form of fat fibrosis is linked to insulin resistance in people with HIV.

JCI insight·2026
Same author

Gα<sub>q</sub> Is a Heterotrimeric G-Protein Subunit That Directs the Selectivity of PPARγ-Induced Gene Pathways Toward Energy-Related Processes Rather than Adiposity.

Metabolites·2026
Same author

Dynamic regulation of circulating endotrophin by changes in fat mass in humans.

Metabolism: clinical and experimental·2026
Same author

Publisher Correction: GLP-1R-GIPR-PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice.

Nature·2026
Same author

GLP-1R-GIPR-PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice.

Nature·2026
Same author

Iron overload in steatotic hepatocytes drives systemic metabolic dysfunction via alterations in hepatokine production.

The Journal of clinical investigation·2026
Same journal

Continuous Glucose Monitoring in Type 2 Diabetes: Clinical Outcomes, Disparities in Access, and Cost-effectiveness.

Current diabetes reports·2026
Same journal

Beyond Inflammation - A Multidisciplinary Approach to Managing Obesity and Cardiometabolic Risk in Inflammatory Bowel Disease.

Current diabetes reports·2026
Same journal

Climate Change and Diabetes Outcomes: Evidence from Climate-Vulnerable Regions.

Current diabetes reports·2026
Same journal

Efficacy and safety of once-weekly basal insulin analogs versus daily basal insulin analogs in adults with type 2 diabetes: a systematic review and meta-analysis.

Current diabetes reports·2026
Same journal

Use of Glucagon-Like Peptide-1 Receptor Agonists in Women with Type 2 Diabetes Before Pregnancy: Addressing the Dilemma in A Real-World Setting.

Current diabetes reports·2026
Same journal

Can Behavioral Interventions Promote Health Equity in Pediatric Type 1 Diabetes? A Narrative Review of Promising Treatments.

Current diabetes reports·2026
See all related articles

Adiponectin, an adipokine hormone, is crucial for maintaining energy balance and insulin sensitivity. Lower levels are linked to metabolic dysfunction like obesity and insulin resistance.

Area of Science:

  • Endocrinology
  • Metabolic Research

Background:

  • Adipose tissue functions as an endocrine organ secreting adipokines.
  • Adipokines, like adiponectin, play key roles in regulating whole-body metabolism and energy homeostasis.
  • Adiponectin is recognized for its role in mediating insulin sensitivity.

Purpose of the Study:

  • To summarize the current understanding of adiponectin's role in insulin sensitivity and metabolic homeostasis.
  • To highlight the association between decreased adiponectin levels and metabolic dysfunction.
  • To underscore the therapeutic potential of adiponectin.

Main Methods:

  • Review of clinical reports and genetic studies in humans and animal models.
  • Analysis of phenotypes from adiponectin-deficient and transgenic animal models.

Related Experiment Videos

  • Examination of results from pharmacologic adiponectin treatments in rodents.

    • Main Results:

    • Decreased circulating adiponectin levels are consistently observed in obesity and insulin resistance.
    • Adiponectin administration in rodents enhances insulin sensitivity.
    • Adiponectin-deficient and overproducing animal models demonstrate its importance in glucose and lipid homeostasis.

    Conclusions:

    • Adiponectin is a critical mediator of insulin sensitivity and metabolic homeostasis.
    • Therapeutic strategies targeting adiponectin may offer new avenues for treating metabolic dysfunction.
    • Further research is needed to elucidate the precise mechanisms and primary sites of adiponectin action.